Adverse effects after Ayahuasca administration in the clinical setting [Carta] (2022)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROCHA, JULIANA MENDES - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- DOI: 10.1097/JCP.0000000000001536
- Subjects: FÁRMACOS (SISTEMA NERVOSO CENTRAL); PLANTAS ALUCINÓGENAS; ALUCINOGÊNICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Journal of Clinical Psychopharmacology
- ISSN: 1533-712X
- Volume/Número/Paginação/Ano: v. 42, n. 3, p. 321-324, 2022
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
ROCHA, Juliana Mendes et al. Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001536. Acesso em: 01 abr. 2026. , 2022 -
APA
Rocha, J. M., Rossi, G. N., Osório, F. de L., Hallak, J. E. C., & Santos, R. G. dos. (2022). Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001536 -
NLM
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/JCP.0000000000001536 -
Vancouver
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/JCP.0000000000001536 - Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies
- Multifaceted Empathy Test (MET): validity evidence for the Brazilian population concerning the computer-based (face-to-face) and online versions
- The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003113622.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
